相似文献
1
Application of magnetic nanoparticles in adoptive cell therapy of cancer; training, guiding and imaging cells.
Nanomedicine (Lond). 2024;19(27):2315-2329. doi: 10.1080/17435889.2024.2395239. Epub 2024 Sep 11.
2
A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy.
Hum Vaccin Immunother. 2025 Dec;21(1):2518634. doi: 10.1080/21645515.2025.2518634. Epub 2025 Jun 17.
3
Engineered T cells for Colorectal Cancer.
Immunotherapy. 2024;16(14-15):987-998. doi: 10.1080/1750743X.2024.2391733. Epub 2024 Sep 4.
4
Comparative evaluation of polymer coated antibody modified SPIONs for tumor detection using magnetic particle imaging.
Nanoscale. 2025 Jul 3;17(26):15815-15828. doi: 10.1039/d5nr00608b.
5
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors.
Semin Immunopathol. 2024 Jul 25;46(3-4):8. doi: 10.1007/s00281-024-01011-y.
6
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
7
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Cochrane Database Syst Rev. 2017 Dec 16;12(12):CD011300. doi: 10.1002/14651858.CD011300.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectives.
Med Oncol. 2025 Jun 15;42(7):261. doi: 10.1007/s12032-025-02808-z.
10
Interventions for promoting habitual exercise in people living with and beyond cancer.
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
引用本文的文献
1
Stimuli-Responsive, Cell-Mediated Drug Delivery Systems: Engineering Smart Cellular Vehicles for Precision Therapeutics.
Pharmaceutics. 2025 Aug 21;17(8):1082. doi: 10.3390/pharmaceutics17081082.
本文引用的文献
1
Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design.
Adv Colloid Interface Sci. 2024 Mar;325:103094. doi: 10.1016/j.cis.2024.103094. Epub 2024 Jan 26.
2
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches.
Stem Cell Rev Rep. 2024 Apr;20(3):585-600. doi: 10.1007/s12015-023-10668-1. Epub 2023 Dec 28.
3
Progress in nanoparticle-based regulation of immune cells.
Med Rev (2021). 2023 Apr 12;3(2):152-179. doi: 10.1515/mr-2022-0047. eCollection 2023 Apr.
4
Engineering a platelet-rich plasma-based multifunctional injectable hydrogel with photothermal, antibacterial, and antioxidant properties for skin regeneration.
Biomater Sci. 2023 Aug 22;11(17):5872-5892. doi: 10.1039/d3bm00881a.
5
Recent progress in the effect of magnetic iron oxide nanoparticles on cells and extracellular vesicles.
Cell Death Discov. 2023 Jun 28;9(1):195. doi: 10.1038/s41420-023-01490-2.
6
CAR-T: What Is Next?
Cancers (Basel). 2023 Jan 21;15(3):663. doi: 10.3390/cancers15030663.
7
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.
Mol Cancer. 2023 Feb 7;22(1):28. doi: 10.1186/s12943-023-01735-9.
8
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment.
Exp Hematol Oncol. 2023 Jan 27;12(1):14. doi: 10.1186/s40164-023-00373-7.
9
Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
Nanomedicine (Lond). 2022 Sep;17(21):1567-1583. doi: 10.2217/nnm-2022-0246. Epub 2022 Dec 2.
10
Cancer treatment by magneto-mechanical effect of particles, a review.
Nanoscale Adv. 2020 Jun 19;2(9):3632-3655. doi: 10.1039/d0na00187b. eCollection 2020 Sep 16.
Zotero 插件